BMY logo

Bristol-Myers Squibb (BMY) Selling, General & Administrative Expenses

BMY Annual SG&A

$7.77 B
-$42.00 M-0.54%

31 December 2023

BMY Selling, General & Administrative Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BMY Quarterly SG&A

$1.98 B
+$55.00 M+2.85%

30 September 2024

BMY Quarterly SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BMY TTM SG&A

$76.61 B
-$12.12 B-13.66%

30 September 2024

BMY TTM SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BMY Selling, General & Administrative Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-0.5%-4.3%+885.7%
3 y3 years+1.4%-4.3%+885.7%
5 y5 years+70.8%-4.3%+885.7%

BMY Selling, General & Administrative Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-0.5%+1.1%-16.2%+12.5%-31.0%at low
5 y5-year-0.5%+59.6%-27.1%+23.5%-46.1%at low
alltimeall time-0.5%+105.1%-27.1%+519.7%-46.1%+1567.5%

Bristol-Myers Squibb Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sept 2024
-
$1.98 B(+2.9%)
$8.35 B(-0.2%)
June 2024
-
$1.93 B(-18.5%)
$8.37 B(-0.1%)
Mar 2024
-
$2.37 B(+14.2%)
$8.38 B(+7.8%)
Dec 2023
$7.77 B(-0.5%)
$2.07 B(+3.5%)
$7.77 B(-2.4%)
Sept 2023
-
$2.00 B(+3.6%)
$7.96 B(+0.9%)
June 2023
-
$1.93 B(+9.8%)
$7.89 B(+1.9%)
Mar 2023
-
$1.76 B(-22.2%)
$7.75 B(-0.9%)
Dec 2022
$7.81 B(+1.6%)
$2.27 B(+17.4%)
$7.81 B(-1.1%)
Sept 2022
-
$1.93 B(+8.0%)
$7.90 B(+1.8%)
June 2022
-
$1.79 B(-2.4%)
$7.76 B(-1.2%)
Mar 2022
-
$1.83 B(-22.2%)
$7.86 B(+2.1%)
Dec 2021
$7.69 B(+0.4%)
$2.35 B(+31.7%)
$7.69 B(-4.6%)
Sept 2021
-
$1.79 B(-5.0%)
$8.06 B(+1.0%)
June 2021
-
$1.88 B(+13.0%)
$7.97 B(+3.3%)
Mar 2021
-
$1.67 B(-38.8%)
$7.72 B(+0.8%)
Dec 2020
$7.66 B(+57.3%)
$2.72 B(+59.5%)
$7.66 B(+14.8%)
Sept 2020
-
$1.71 B(+4.8%)
$6.67 B(+10.8%)
June 2020
-
$1.63 B(+1.4%)
$6.02 B(+10.1%)
Mar 2020
-
$1.61 B(-7.4%)
$5.47 B(+12.3%)
Dec 2019
$4.87 B(+7.0%)
$1.73 B(+64.4%)
$4.87 B(+8.9%)
Sept 2019
-
$1.05 B(-2.0%)
$4.47 B(-1.1%)
June 2019
-
$1.08 B(+7.0%)
$4.52 B(-1.2%)
Mar 2019
-
$1.01 B(-24.7%)
$4.58 B(+0.6%)
Dec 2018
$4.55 B(-4.2%)
$1.34 B(+21.0%)
$4.55 B(+0.4%)
Sept 2018
-
$1.10 B(-2.4%)
$4.53 B(-1.3%)
June 2018
-
$1.13 B(+15.4%)
$4.59 B(-1.2%)
Mar 2018
-
$980.00 M(-25.5%)
$4.65 B(-2.2%)
Dec 2017
$4.75 B(-4.6%)
$1.32 B(+13.2%)
$4.75 B(-3.0%)
Sept 2017
-
$1.16 B(-2.0%)
$4.90 B(0.0%)
June 2017
-
$1.19 B(+9.4%)
$4.90 B(-1.5%)
Mar 2017
-
$1.08 B(-25.8%)
$4.97 B(-0.1%)
Dec 2016
$4.98 B(-0.4%)
$1.46 B(+25.8%)
$4.98 B(-1.7%)
Sept 2016
-
$1.16 B(-7.9%)
$5.07 B(-1.2%)
June 2016
-
$1.26 B(+15.9%)
$5.13 B(+1.8%)
Mar 2016
-
$1.09 B(-29.7%)
$5.04 B(+0.7%)
Dec 2015
$5.00 B(-12.2%)
$1.55 B(+26.6%)
$5.00 B(-10.0%)
Sept 2015
-
$1.22 B(+4.5%)
$5.55 B(-0.1%)
June 2015
-
$1.17 B(+10.9%)
$5.56 B(-0.2%)
Mar 2015
-
$1.06 B(-49.8%)
$5.57 B(-2.2%)
Dec 2014
$5.70 B(+11.7%)
$2.10 B(+71.3%)
$5.70 B(+15.3%)
Sept 2014
-
$1.23 B(+3.8%)
$4.94 B(+0.3%)
June 2014
-
$1.18 B(-0.1%)
$4.93 B(-3.5%)
Mar 2014
-
$1.18 B(-12.2%)
$5.11 B(+0.0%)
Dec 2013
$5.10 B(-1.4%)
$1.35 B(+11.4%)
$5.10 B(-3.1%)
Sept 2013
-
$1.21 B(-11.0%)
$5.26 B(-0.6%)
June 2013
-
$1.36 B(+15.0%)
$5.29 B(+2.6%)
Mar 2013
-
$1.18 B(-21.7%)
$5.16 B(-0.3%)
Dec 2012
$5.17 B(+0.1%)
$1.51 B(+21.7%)
$5.17 B(-0.0%)
Sept 2012
-
$1.24 B(+1.1%)
$5.18 B(+0.3%)
June 2012
-
$1.23 B(+2.7%)
$5.16 B(-1.2%)
Mar 2012
-
$1.20 B(-20.8%)
$5.22 B(+1.0%)
Dec 2011
$5.17 B(+10.2%)
$1.51 B(+23.4%)
$5.17 B(+4.3%)
Sept 2011
-
$1.22 B(-5.3%)
$4.96 B(+2.1%)
June 2011
-
$1.29 B(+13.2%)
$4.86 B(+2.9%)
Mar 2011
-
$1.14 B(-12.1%)
$4.72 B(+0.6%)
Dec 2010
$4.69 B(-10.0%)
$1.30 B(+15.7%)
$4.69 B(-4.2%)
Sept 2010
-
$1.12 B(-2.9%)
$4.90 B(-1.7%)
June 2010
-
$1.16 B(+4.0%)
$4.98 B(-1.8%)
Mar 2010
-
$1.11 B(-26.1%)
$5.07 B(-2.7%)
Dec 2009
$5.21 B(-2.6%)
$1.50 B(+24.4%)
$5.21 B(+17.0%)
Sept 2009
-
$1.21 B(-3.1%)
$4.46 B(-7.5%)
June 2009
-
$1.25 B(-0.4%)
$4.82 B(-6.5%)
Mar 2009
-
$1.25 B(+68.0%)
$5.15 B(-3.7%)
Dec 2008
$5.35 B(-15.3%)
$746.00 M(-52.5%)
$5.35 B(-20.3%)
Sept 2008
-
$1.57 B(-0.9%)
$6.72 B(+1.9%)
June 2008
-
$1.58 B(+9.1%)
$6.59 B(+2.0%)
Mar 2008
-
$1.45 B(-31.1%)
$6.46 B(+0.8%)
Dec 2007
$6.32 B(+2.9%)
$2.11 B(+46.2%)
$6.41 B(+8.7%)
Sept 2007
-
$1.44 B(-1.0%)
$5.90 B(-0.5%)
June 2007
-
$1.46 B(+4.0%)
$5.93 B(-1.3%)
Mar 2007
-
$1.40 B(-12.4%)
$6.01 B(-2.1%)
DateAnnualQuarterlyTTM
Dec 2006
$6.14 B(-4.9%)
$1.60 B(+8.4%)
$6.14 B(-1.4%)
Sept 2006
-
$1.48 B(-3.8%)
$6.22 B(-2.5%)
June 2006
-
$1.53 B(0.0%)
$6.38 B(-1.5%)
Mar 2006
-
$1.53 B(-9.0%)
$6.49 B(+0.5%)
Dec 2005
$6.45 B(+0.4%)
$1.68 B(+3.0%)
$6.45 B(-2.0%)
Sept 2005
-
$1.64 B(+0.1%)
$6.58 B(+1.7%)
June 2005
-
$1.63 B(+8.8%)
$6.47 B(+1.3%)
Mar 2005
-
$1.50 B(-17.3%)
$6.39 B(-0.6%)
Dec 2004
$6.43 B(+6.5%)
$1.81 B(+19.0%)
$6.43 B(+2.8%)
Sept 2004
-
$1.52 B(-1.5%)
$6.25 B(+0.7%)
June 2004
-
$1.55 B(+0.3%)
$6.21 B(+0.7%)
Mar 2004
-
$1.54 B(-5.7%)
$6.16 B(+2.1%)
Dec 2003
$6.04 B(+14.6%)
$1.64 B(+10.3%)
$6.04 B(+1.6%)
Sept 2003
-
$1.48 B(-1.2%)
$5.94 B(+3.7%)
June 2003
-
$1.50 B(+6.1%)
$5.73 B(+4.0%)
Mar 2003
-
$1.42 B(-8.2%)
$5.51 B(+4.6%)
Dec 2002
$5.27 B(+1.4%)
$1.54 B(+21.1%)
$5.27 B(+2.7%)
Sept 2002
-
$1.27 B(-0.7%)
$5.13 B(+1.7%)
June 2002
-
$1.28 B(+9.5%)
$5.04 B(-2.1%)
Mar 2002
-
$1.17 B(-16.5%)
$5.15 B(-2.2%)
Dec 2001
$5.19 B(-6.1%)
$1.40 B(+18.2%)
$5.27 B(+1.5%)
Sept 2001
-
$1.19 B(-14.7%)
$5.19 B(-3.2%)
June 2001
-
$1.39 B(+7.9%)
$5.36 B(-9.0%)
Mar 2001
-
$1.29 B(-2.9%)
$5.89 B(-0.8%)
Dec 2000
$5.53 B(+3.6%)
$1.33 B(-2.3%)
$5.93 B(-2.7%)
Sept 2000
-
$1.36 B(-29.2%)
$6.10 B(+1.6%)
June 2000
-
$1.92 B(+43.8%)
$6.00 B(+2.2%)
Mar 2000
-
$1.33 B(-10.5%)
$5.87 B(-5.1%)
Dec 1999
$5.34 B(+2.6%)
$1.49 B(+18.1%)
$6.19 B(+23.3%)
Sept 1999
-
$1.26 B(-29.4%)
$5.02 B(-6.1%)
June 1999
-
$1.79 B(+8.4%)
$5.35 B(+2.1%)
Mar 1999
-
$1.65 B(+415.6%)
$5.23 B(+0.6%)
Dec 1998
$5.20 B(-18.9%)
$320.00 M(-79.8%)
$5.20 B(-22.1%)
Sept 1998
-
$1.59 B(-5.3%)
$6.68 B(+1.4%)
June 1998
-
$1.68 B(+3.5%)
$6.59 B(+1.0%)
Mar 1998
-
$1.62 B(-9.7%)
$6.53 B(+1.7%)
Dec 1997
$6.41 B(+9.2%)
$1.79 B(+19.6%)
$6.41 B(+2.9%)
Sept 1997
-
$1.50 B(-7.1%)
$6.23 B(+2.5%)
June 1997
-
$1.61 B(+7.0%)
$6.08 B(+1.9%)
Mar 1997
-
$1.51 B(-6.5%)
$5.97 B(+1.7%)
Dec 1996
$5.87 B(+10.4%)
$1.61 B(+19.8%)
$5.87 B(+1.9%)
Sept 1996
-
$1.35 B(-10.4%)
$5.76 B(+2.0%)
June 1996
-
$1.50 B(+6.5%)
$5.64 B(+2.2%)
Mar 1996
-
$1.41 B(-6.1%)
$5.52 B(+3.9%)
Dec 1995
$5.32 B(+17.3%)
$1.50 B(+21.8%)
$5.32 B(+3.5%)
Sept 1995
-
$1.23 B(-10.7%)
$5.14 B(+4.2%)
June 1995
-
$1.38 B(+14.8%)
$4.93 B(+4.1%)
Mar 1995
-
$1.20 B(-9.1%)
$4.73 B(+4.5%)
Dec 1994
$4.53 B(-24.2%)
$1.32 B(+29.1%)
$4.53 B(-14.4%)
Sept 1994
-
$1.02 B(-13.6%)
$5.30 B(-4.5%)
June 1994
-
$1.19 B(+18.5%)
$5.55 B(-3.4%)
Mar 1994
-
$1.00 B(-52.1%)
$5.74 B(-3.9%)
Dec 1993
$5.98 B(-5.6%)
$2.09 B(+63.6%)
$5.98 B(+0.1%)
Sept 1993
-
$1.28 B(-7.6%)
$5.97 B(-3.2%)
June 1993
-
$1.38 B(+11.7%)
$6.17 B(-1.3%)
Mar 1993
-
$1.24 B(-40.6%)
$6.25 B(-1.4%)
Dec 1992
$6.34 B(+16.0%)
$2.08 B(+41.3%)
$6.34 B(+8.4%)
Sept 1992
-
$1.47 B(+0.6%)
$5.85 B(+3.8%)
June 1992
-
$1.46 B(+10.5%)
$5.64 B(+2.5%)
Mar 1992
-
$1.32 B(-16.7%)
$5.50 B(+0.7%)
Dec 1991
$5.46 B(+8.5%)
$1.59 B(+26.2%)
$5.46 B(+1.6%)
Sept 1991
-
$1.26 B(-4.9%)
$5.38 B(+1.4%)
June 1991
-
$1.32 B(+2.9%)
$5.30 B(+2.8%)
Mar 1991
-
$1.29 B(-14.5%)
$5.16 B(+2.5%)
Dec 1990
$5.04 B(-7.6%)
$1.51 B(+27.0%)
$5.04 B(+42.7%)
Sept 1990
-
$1.19 B(+0.3%)
$3.53 B(+50.6%)
June 1990
-
$1.18 B(+1.6%)
$2.35 B(+101.6%)
Mar 1990
-
$1.16 B
$1.16 B
Dec 1989
$5.45 B(+26.6%)
-
-
Dec 1988
$4.30 B(+13.6%)
-
-
Dec 1987
$3.79 B
-
-

FAQ

  • What is Bristol-Myers Squibb annual selling, general & administrative expenses?
  • What is the all time high annual SG&A for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb annual SG&A year-on-year change?
  • What is Bristol-Myers Squibb quarterly selling, general & administrative expenses?
  • What is the all time high quarterly SG&A for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb quarterly SG&A year-on-year change?
  • What is Bristol-Myers Squibb TTM selling, general & administrative expenses?
  • What is the all time high TTM SG&A for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb TTM SG&A year-on-year change?

What is Bristol-Myers Squibb annual selling, general & administrative expenses?

The current annual SG&A of BMY is $7.77 B

What is the all time high annual SG&A for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high annual selling, general & administrative expenses is $7.81 B

What is Bristol-Myers Squibb annual SG&A year-on-year change?

Over the past year, BMY annual selling, general & administrative expenses has changed by -$42.00 M (-0.54%)

What is Bristol-Myers Squibb quarterly selling, general & administrative expenses?

The current quarterly SG&A of BMY is $1.98 B

What is the all time high quarterly SG&A for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high quarterly selling, general & administrative expenses is $2.72 B

What is Bristol-Myers Squibb quarterly SG&A year-on-year change?

Over the past year, BMY quarterly selling, general & administrative expenses has changed by -$90.00 M (-4.34%)

What is Bristol-Myers Squibb TTM selling, general & administrative expenses?

The current TTM SG&A of BMY is $76.61 B

What is the all time high TTM SG&A for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high TTM selling, general & administrative expenses is $8.38 B

What is Bristol-Myers Squibb TTM SG&A year-on-year change?

Over the past year, BMY TTM selling, general & administrative expenses has changed by +$68.83 B (+885.67%)